These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent developments in diisocyanate asthma. Liu Q, Wisnewski AV. Ann Allergy Asthma Immunol; 2003 May; 90(5 Suppl 2):35-41. PubMed ID: 12772950 [Abstract] [Full Text] [Related]
3. The guinea pig model of diisocyanate sensitization. II. Physiologic studies. Bernstein IL, Splansky GL, Chen SE, Vinegar A. J Allergy Clin Immunol; 1982 Nov; 70(5):393-8. PubMed ID: 6290555 [No Abstract] [Full Text] [Related]
4. Evaluation of antibody binding to diisocyanate protein conjugates in a general population. Bernstein DI, Ott MG, Woolhiser M, Lummus Z, Graham C. Ann Allergy Asthma Immunol; 2006 Sep; 97(3):357-64. PubMed ID: 17042142 [Abstract] [Full Text] [Related]
7. Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthma. Lummus ZL, Alam R, Bernstein JA, Bernstein DI. J Allergy Clin Immunol; 1998 Aug; 102(2):265-74. PubMed ID: 9723671 [Abstract] [Full Text] [Related]
8. Experiences of specific IgE in asthma due to diisocyanates. Keskinen H, Tupasela O, Tiikkainen U, Nordman H. Clin Allergy; 1988 Nov; 18(6):597-604. PubMed ID: 2854010 [Abstract] [Full Text] [Related]
9. Specific immunoglobulin E and immunoglobulin G antibodies to toluene diisocyanate-human serum albumin conjugate: useful markers for predicting long-term prognosis in toluene diisocyanate-induced asthma. Park HS, Lee SK, Kim HY, Nahm DH, Kim SS. Clin Exp Allergy; 2002 Apr; 32(4):551-5. PubMed ID: 11972601 [Abstract] [Full Text] [Related]